Garry Arthur Neil, Chief Scientific Officer at Aevi Genomic Medicine, Inc. (GNMX), bought 4,098,752 shares at $0.13 ($533K) on 2019-12-05, disclosed to the SEC on 2019-12-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.13 | 2,049,376 | $266K | 50.0% |
| 2 | $0.13 | 2,049,376 | $266K | 50.0% |
| Total | $0.13 avg | 4,098,752 | $533K | 100% |
| Filing → |
| AVTX | BUY | 2021-12-14 | $7K | — | Filing → |
| CERC | BUY | 2021-06-14 | $8K | — | Filing → |
| CERC | BUY | 2020-12-14 | $8K | — | Filing → |